National Institute of Neurological Disorders and Stroke Revenue and Competitors
Estimated Revenue & Valuation
- National Institute of Neurological Disorders and Stroke's estimated annual revenue is currently $69.6M per year.
- National Institute of Neurological Disorders and Stroke's estimated revenue per employee is $127,500
Employee Data
- National Institute of Neurological Disorders and Stroke has 546 Employees.
- National Institute of Neurological Disorders and Stroke grew their employee count by 13% last year.
National Institute of Neurological Disorders and Stroke's People
Name | Title | Email/Phone |
---|---|---|
1 | Program Director, Movement Disorders and Neurodegeneration | Reveal Email/Phone |
2 | Program Director | Reveal Email/Phone |
National Institute of Neurological Disorders and Stroke Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.9M | 77 | N/A | N/A | N/A |
#2 | $557.1M | 3901 | 5% | N/A | N/A |
#3 | $4M | 49 | -6% | N/A | N/A |
#4 | $3.8M | 46 | 7% | N/A | N/A |
#5 | $2.6M | 35 | N/A | N/A | N/A |
#6 | $21M | 187 | N/A | N/A | N/A |
#7 | $2.1M | 29 | -19% | N/A | N/A |
#8 | $279.6M | 1958 | N/A | N/A | N/A |
#9 | $67.1M | 526 | 5% | N/A | N/A |
#10 | $706.1M | 4945 | N/A | N/A | N/A |
What Is National Institute of Neurological Disorders and Stroke?
Privacy Notice & Comment Policy Medical Disclaimer: The advice provided through the NINDS LinkedIn page is for informational purposes only and is not a substitute for professional medical advice. You should consult a healthcare provider in all matters relating to your health. Commenting Guideline: Please be aware that your comment may be removed if it contains material that is offensive, commercial, or unrelated to this page. Your Privacy The U.S. Department of Health and Human Services participates in this open forum in order to increase government transparency, enhance information sharing, promote public participation, and encourage collaboration with the Department. Please note that LinkedIn is not a government website or application; it is controlled or operated by LinkedIn, and HHS's Privacy Policy does not apply. HHS does not own, manage, or control LinkedIn. In addition, HHS does not collect, maintain or disseminate information posted here. If you choose to provide information to LinkedIn through registration or other interaction with the site, such actions are between you and LinkedIn. Any information that you provide to register on LinkedIn is voluntarily contributed and is not maintained by any HHS entity. HHS does not collect, maintain or disseminate the information you provide to LinkedIn. Although you may voluntarily contribute to LinkedIn with the intent to share the information with others on the LinkedIn LinkedIn Page, to protect your privacy, please do not disclose personally identifiable information about yourself or others. More information on our privacy notice and comment policy http://www.hhs.gov/web/socialmedia/policies/comment-policy.html Visit www.HHS.gov for information on how to send official correspondence to the Department of Health and Human Services
keywords:N/AN/A
Total Funding
546
Number of Employees
$69.6M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
National Institute of Neurological Disorders and Stroke News
The SUDEP Institute is dedicated to helping drive efforts to improve SUDEP ... the National Institute of Neurological Disorders and Stroke (NINDS),...
CHICAGO --- There are five different diseases that attack the language ... from the National Institute on Neurological Disorders and Stroke,...
Ischemic strokes are caused by blocked blood flow in the brain, ... The U.S. National Institute of Neurological Disorders and Stroke has...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $178.8M | 563 | 27% | N/A |
#2 | $192.4M | 606 | 11% | N/A |
#3 | $106.6M | 609 | 23% | N/A |
#4 | $205.9M | 610 | 5% | N/A |
#5 | $300M | 633 | -4% | N/A |